(Q40499571)

English

Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities

scientific article published on 26 October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

vaccine engineering

1 reference

based on heuristic

inferred from title

author name string

Naveen K Dakappagari

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kenneth D Lute

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sharad Rawale

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Joan T Steele

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Stephanie D Allen

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gary Phillips

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

R Todd Reilly

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pravin T P Kaumaya

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

26 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

280

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

54-63

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Targeting HER2 in other tumor types

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Disulfide bond structure of human epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Disabling receptor ensembles with rationally designed interface peptidomimetics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

trans-Dichlorotetracyanoplatinate(IV) as a Reagent for the Rapid and Quantitative Formation of Intramolecular Disulfide Bonds in Peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

beta-Sheet is the bioactive conformation of the anti-angiogenic anginex peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Synthesis and conformational analysis of the insulin-like 4 gene product

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

A new spectroscopic approach to examining the role of disulfide bonds in the structure and unfolding of soybean trypsin inhibitor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Endogenous interferon-gamma acts directly on tumor cells in vivo to suppress growth.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

A structure-based approach to a synthetic vaccine for HIV-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411020200

21 January 2018

Identifiers

10.1074/JBC.M411020200

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40499571&oldid=1899395333"